enGene Therapeutics Inc. (ENGN): 10-Q filed Sep 8, 2026

Form type

10-Q

Filing date

Sep 8, 2026

Accession number

0001193125-26-384383

Filer

enGene Therapeutics Inc. (CIK 1980845)